View More Recent Stories
-
Wells Fargo Downgrades Zymeworks (ZYME) to Equal Weight
-
Zymeworks (ZYME) Misses Q3 EPS by 39c
-
Zymeworks (ZYME) PT Raised to $28 at Stifel
-
H.C. Wainwright Reiterates Neutral Rating on Zymeworks (ZYME)
-
Zymeworks (ZYME) Announces Resignation of Hollings C. Renton
-
Zymeworks (ZYME) PT Raised to $12 at H.C. Wainwright
-
H.C. Wainwright Reiterates Neutral Rating on Zymeworks (ZYME)
-
Stifel Reiterates Buy Rating on Zymeworks (ZYME)
-
Zymeworks (ZYME) Misses Q2 EPS by 49c
-
Zymeworks (ZYME) Announces $60M Share Buyback
-
Zymeworks (ZYME) Appoints Leone Patterson as Chief Business and Financial Officer
-
Zymeworks (ZYME) Receives FDA Clearance of Investigational New Drug Application for ZW191
-
Zymeworks (ZYME) Announces FDA Clearance of IND Application for ZW171
-
Zymeworks (ZYME) Announces China NMPA Acceptance of BLA for Zanidatamab

